ARCHIVES

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

This article is from The Cancer Letter archive.

Vol. 23 No. 29 | July 25, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

ASCO Awards Contract For D.C Office

January 12, 1990

AACR, ASCO Continue Growth, Drop Idea Of “Cancer Week”

July 1, 1988

NCI Plans Program To Help Academics With Initial Stages of Drug Discovery.

November 30, 2007

Colonoscopy Every Three Years Indicated For Those With Family History Of Polyps

May 31, 2002

Group Urges U.S., USSR Exchange In Surgical Oncology

January 6, 1989